Karamvir Yadav, Medical Oncologist in Jaipur, India, shared a post on X:
“Continue TKI during RT – or hold?
The ESMO-ESTRO consensus provides practical guidance:
- Most high-dose RT – Major adaptation
- Skin toxicity signal strong with BRAF/MEK
- Clear “Do NOT combine” scenarios defined
Data limited. Decisions must be multidisciplinary.”
Other articles featuring Karamvir Yadav on OncoDaily.